Products
Active Pharmaceutical Ingredients
| Product | CAS NO. | Therapeutic Category | CHINA | US | EU | JAPAN | OTHERS |
|---|---|---|---|---|---|---|---|
| Aprepitant | 170729-80-3 | Oncology | ▲ | ▲ | CEP | ▲ | CTD |
| Bisoprolol Fumarate | 104344-23-2 | Cardiovascular | GMP | CEP | JDMF | CTD | |
| Brexpiprazole | 913611-97-9 | Neurology & Psychiatry | ▲ | TP | |||
| Dabigatran Etexilate Mesylate | 872728-81-9 | Cardiovascular | Approved | USDMF | ▲ | JDMF | CTD |
| Dabigatran Etexilate Mesylate Pellet | 872728-81-9 | Cardiovascular | Approved | CTD | |||
| Ibandronate Sodium | 138926-19-9 | Oncology | GMP | TP | |||
| Lenvatinib Mesylate | 417716-92-8 | Oncology | ▲ | ▲ | ▲ | ▲ | TP |
| Parecoxib Sodium | 198470-85-8 | Anesthetic & Analgesics | GMP | CTD | |||
| Rotigotine | 99755-59-6 | Neurology & Psychiatry | ▲ | ▲ | ▲ | ▲ | CTD |
| Silodosin | 160970-54-7 | Urinary system | ▲ | ▲ | JDMF | CTD | |
| Sodium Fusidate | 751-94-0 | Anti-inflammatory | GMP | CTD | |||
| Sugammadex Sodium | 343306-79-6 | Anesthetic & Analgesics | Under Approval | ▲ | CTD | ||
| Ticagrelor | 274693-27-5 | Cardiovascular | Under Approval | USDMF | ▲ | ▲ | CTD |
| Ubenimex | 58970-76-6 | Oncology | GMP | JDMF | CTD |
▲ CTD dossier under filling/preparation
According to laws and regulations of People's Republic of China, relevant information of Schedule II Controlled Substance APIs is not released here.
Disclaimer: The product that is still under patent protection can only be used in research and development, not for commercial purpose.
This website does not publish the product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations of medical institutions.
| 
Copyright © 成都尊龙凯时人生就是博·中国生物制药股份有限公司 ALL Rights Reserved
互联网药品信息服务资格证编号：(川)-非经营性-2021-0036
网站备案/许可证号：蜀ICP备12013286号-1